Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Jul. 30, 2022	Jul. 31, 2021	Jul. 30, 2022	Jul. 31, 2021	Oct. 30, 2021
Cash flows from operating activities:
Net income	$ 748,985	$ 503,311	$ 1,812,335	$ 1,314,735
Adjustments to reconcile net income to net cash provided by operations:
Depreciation			212,635	158,937
Amortization of intangibles			1,512,250	436,734
Stock-based compensation expense			242,809	118,683
Non-cash impairment charge			91,953	0
Gain on sale of property, plant, and equipment			(4,352)	(13,557)
Cost of goods sold for inventory acquired			271,396	0
Deferred income taxes			(205,128)	(72,578)
Non-cash operating lease costs			(17,958)	16,855
Other			(7,061)	(14,965)
Changes in operating assets and liabilities			(582,813)	(150,499)
Total adjustments			1,513,731	479,610
Net cash provided by operating activities			3,326,066	1,794,345
Cash flows from investing activities:
Additions to property, plant and equipment			(394,796)	(212,899)
Other			43,761	29,619
Net cash used for investing activities			(351,035)	(183,280)
Cash flows from financing activities:
Proceeds from revolver			400,000	0
Payments on revolver			400,000	0
Early termination of debt			(519,116)	0
Dividend payments to shareholders			(1,154,207)	(738,114)
Repurchase of common stock			(1,758,832)	(509,152)
Proceeds from employee stock plans			30,013	55,348
Other			(1,718)	1,952
Net cash used for financing activities			(3,403,860)	(1,189,966)
Effect of exchange rate changes on cash			(24,175)	3,742
Net (decrease) increase in cash and cash equivalents			(453,004)	424,841
Cash and cash equivalents at beginning of period			1,977,964	1,055,860	$ 1,055,860
Cash and cash equivalents at end of period	$ 1,524,960	$ 1,480,701	$ 1,524,960	$ 1,480,701	$ 1,977,964